On-site adsorption equipment for urokinase and ulinastatin
By designing a urokinase and urokinase adsorption device including a urokinase reservoir, a urotinatine adsorption device and a urokinase adsorption device, the problem of urine storage and transportation in existing equipment is solved, and the automated adsorption and efficient treatment of urokinase and urotinatine are realized.
Patent Information
- Application Number
- CN202421645481.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Utility models(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-12
- Publication Date
- 2025-04-18
- Estimated Expiration
- 2034-07-12
AI Technical Summary
The existing urokinase and urinatine adsorption and collection equipment have problems such as long-term urine storage time, high transportation costs, occupying the site and polluting the environment, and it is difficult to meet the effective adsorption and treatment needs of urinatine and urinatine.
A urokinase and urstard on-site adsorption equipment was designed, including a urinary reservoir, urinarystatin adsorption device and urinary kinase adsorption device. Through a liquid circulation system composed of components such as circulating catheter group and liquid extraction pump, the automatic and uniform adsorption of urine is achieved, reducing transportation and storage needs.
The device can automatically adsorb urokinase and urstatine on site, reduce transportation and labor costs, improve economic benefits, and achieve precise control through flowmeters to improve product quality and activity.
Smart Images

Figure CN222765717U_ABST
Abstract
Description
Technical Field
[0001] The utility model relates to the technical field of urokinase and ulinastatin adsorption processing, in particular to a urokinase and ulinastatin on-site adsorption device. Background Art
[0002] Urokinase is suitable for people suffering from cerebral embolism, myocardial infarction, etc., while ulinastatin is a natural anti-inflammatory substance. Both urokinase and ulinastatin can be adsorbed and extracted from urine. This process often requires the use of corresponding urokinase and ulinastatin adsorption and collection equipment.
[0003] Since the adsorption and collection equipment of urokinase and ulinastatin often needs to go through the steps of urine collection and storage, urine transportation and container stirring, it is easy to have defects such as urine deterioration due to long storage time, high transportation cost, occupying space and polluting the environment, which is not conducive to the adsorption, collection and treatment of urokinase and ulinastatin, and can no longer meet people's needs. Therefore, we propose a new type of urokinase and ulinastatin on-site adsorption equipment to solve the above-mentioned disadvantages. Utility Model Content
[0004] The utility model aims to provide an on-site adsorption device for urokinase and ulinastatin to solve the problems raised in the above-mentioned background technology.
[0005] To achieve the above object, the utility model provides the following technical solutions: a urokinase and ulinastatin on-site adsorption device, comprising a urine storage tank, and
[0006] An ulinastatin adsorption device and a urokinase adsorption device, wherein the ulinastatin adsorption device and the urokinase adsorption device are both arranged at one end of the urine storage tank, a urine supply tube is connected between the urine storage tank and the urokinase adsorption device, and a liquid extraction pump and a flow meter are sequentially installed on the urine supply tube;
[0007] A circulation catheter group is arranged between the ulinastatin adsorption device and the urokinase adsorption device, one end of the circulation catheter group is equipped with a first circulation pump and a first conversion three-way valve connected to the urokinase adsorption device, the other end of the circulation catheter group is equipped with a second circulation pump and a third conversion three-way valve connected to the ulinastatin adsorption device, and a second conversion three-way valve is arranged between the circulation catheter group and the urine supply tube;
[0008] The ulinastatin adsorption device is provided with a first filter barrel, a first injection column and a first reaction container in sequence, and the urokinase adsorption device is provided with a second filter barrel, a second injection column and a third reaction container in sequence.
[0009] Furthermore, the liquid extraction pump and the flow meter are respectively installed at the bottom and the top of the urine supply tube.
[0010] Furthermore, a liquid level detector is installed on the urine storage tank, and a pH value detector is installed inside the liquid level detector.
[0011] Furthermore, the ulinastatin adsorption device and the urokinase adsorption device are connected by welding.
[0012] Furthermore, the inner side walls of the ulinastatin adsorption device and the urokinase adsorption device are both provided with nano-ceramic anti-stick coatings.
[0013] Furthermore, a sewage pipe is provided at the bottom end of the urine supply tube, and a solenoid valve is installed on the sewage pipe.
[0014] Compared with the prior art, the beneficial effects of the utility model are:
[0015] The urokinase and ulinastatin on-site adsorption device is equipped with a liquid extraction pump, etc., so that when the device is used, on the one hand, the device uses the second conversion three-way valve connected between the ulinastatin adsorption device and the urokinase adsorption device, the first circulation pump, the circulation catheter group, the second circulation pump, the third conversion three-way valve and the first conversion three-way valve to form a liquid circulation system, and cooperates with the high-pressure pumping liquid of the liquid extraction pump to press urine from the bottom into the urokinase adsorption device, and after the reaction treatment is sequentially passed through the corresponding second filter barrel, the second injection column and the third reaction container inside the urokinase adsorption device, it is subsequently pressed into the bottom pipeline to form a cycle, which is convenient for the uniform adsorption of urokinase. At the same time, the urine is After the enzyme adsorption is completed, the urine enters the ulinastatin adsorption device through the above-mentioned circulation system, and is sequentially subjected to the corresponding first filter barrel, the first injection column and the first reaction container inside the ulinastatin adsorption device for reaction treatment, and then is pressed in from the bottom pipe to form a circulation, so as to facilitate the uniform adsorption of ulinastatin. This enables the device to automatically adsorb urokinase and ulinastatin on site, thereby reducing transportation costs and labor costs and improving economic benefits. On the other hand, by installing a flow meter on the feeding structure composed of the urine supply tube and the liquid suction pump, an intelligent and high-precision flow control function is realized, which can accurately control the material ratio of the product, reduce labor, and at the same time improve the quality and activity of the product and facilitate promotion. BRIEF DESCRIPTION OF THE DRAWINGS
[0016] Figure 1 This is a schematic diagram of the front view structure of the utility model;
[0017] Figure 2 This is a rear structural schematic diagram of the ulinastatin adsorption device of the utility model;
[0018] Figure 3 This is a schematic diagram of a partial cross-sectional structure of a urokinase adsorption device of the utility model viewed from above;
[0019] Figure 4 This is a schematic diagram of the first three-dimensional structure of the ulinastatin adsorption device of the utility model;
[0020] Figure 5 It is a schematic diagram of the second three-dimensional structure of the ulinastatin adsorption device of the utility model.
[0021] In the figure: 1. Ulinastatin adsorption device; 2. Urokinase adsorption device; 3. Flow meter; 4. Second conversion three-way valve; 5. Liquid pump; 6. First circulation pump; 7. Circulation catheter group; 8. Second circulation pump; 9. Third conversion three-way valve; 10. First conversion three-way valve; 11. pH value detector; 12. Urine storage tank; 13. Liquid level detector; 15. First filter barrel; 16. First injection column; 17. First reaction container; 18. Solenoid valve; 19. Sewage pipe; 21. Urine supply tube; 22. Second filter barrel; 23. Second injection column; 24. Third reaction container. DETAILED DESCRIPTION
[0022] It should be noted that, in the absence of conflict, the embodiments and features in the embodiments of the present application can be combined with each other. The present utility model will be described in detail below with reference to the accompanying drawings and in combination with the embodiments.
[0023] It should be noted that, unless otherwise specified, all technical and scientific terms used in this application have the same meanings as commonly understood by ordinary technicians in the technical field to which this application belongs.
[0024] In the present invention, unless otherwise specified, the directional words used, such as "up, down, top, bottom", usually refer to the directions shown in the drawings, or to the components themselves in the vertical, perpendicular or gravity directions; similarly, for ease of understanding and description, "inside and outside" refer to the inside and outside relative to the outline of each component itself, but the above-mentioned directional words are not used to limit the present invention.
[0025] See also Figure 1-5 The utility model provides an embodiment: a urokinase and ulinastatin on-site adsorption device, including a urine storage tank 12, and also including
[0026] The ulinastatin adsorption device 1 and the urokinase adsorption device 2 are both arranged at one end of the urine storage tank 12, a urine supply tube 21 is connected between the urine storage tank 12 and the urokinase adsorption device 2, and a liquid extraction pump 5 and a flow meter 3 are sequentially installed on the urine supply tube 21;
[0027] When in use, by installing a flow meter 3 on the feeding structure composed of the urine supply tube 21 and the liquid pump 5, an intelligent high-precision flow control function is achieved, which can accurately control the material ratio of the product, reduce labor, and improve the quality and activity of the product;
[0028] A circulation catheter group 7 is arranged between the ulinastatin adsorption device 1 and the urokinase adsorption device 2, one end of the circulation catheter group 7 is installed with a first circulation pump 6 and a first conversion three-way valve 10 connected to the urokinase adsorption device 2, the other end of the circulation catheter group 7 is installed with a second circulation pump 8 and a third conversion three-way valve 9 connected to the ulinastatin adsorption device 1, and a second conversion three-way valve 4 is arranged between the circulation catheter group 7 and the urine supply tube 21;
[0029] The first filter barrel 15, the first injection column 16 and the first reaction container 17 are sequentially installed inside the ulinastatin adsorption device 1, and the second filter barrel 22, the second injection column 23 and the third reaction container 24 are sequentially installed inside the urokinase adsorption device 2;
[0030] When in use, the device utilizes the liquid circulation system composed of the second conversion three-way valve 4, the first circulation pump 6, the circulation catheter group 7, the second circulation pump 8, the third conversion three-way valve 9 and the first conversion three-way valve 10 connected between the ulinastatin adsorption device 1 and the urokinase adsorption device 2, and cooperates with the high-pressure pumping action of the liquid pump 5 to press urine from the bottom into the urokinase adsorption device 2, and after reaction treatment in the corresponding second filter barrel 22, the second injection column 23 and the third reaction container 24 in the urokinase adsorption device 2 in turn, it is subsequently pressed into the bottom pipeline to form a cycle, so that urine can be discharged from the urokinase adsorption device 2. At the same time, after the adsorption of urokinase is completed, the urine enters the ulinastatin adsorption device 1 through the above-mentioned circulation system, and is sequentially subjected to the reaction treatment of the first filter barrel 15, the first injection column 16 and the first reaction container 17 corresponding to the ulinastatin adsorption device 1, and then is pressed into the bottom pipeline to form a circulation, which is convenient for the uniform adsorption of ulinastatin. This enables the device to automatically adsorb urokinase and ulinastatin on site, reduces transportation costs and labor costs, improves economic benefits, and relies on the flow meter 3 to accurately control the raw material ratio, thereby improving the quality and activity of the product;
[0031] The liquid pump 5 and the flow meter 3 are installed at the bottom and top of the urine supply tube 21 respectively;
[0032] A liquid level detector 13 is installed on the urine storage tank 12, and a pH value detector 11 is installed inside the liquid level detector 13;
[0033] When in use, the liquid level detector 13 can be used to monitor the liquid level inside the urine storage tank 12 in real time, which is convenient for the external control device to set the alarm interval, and the pH value detector 11 can be used to monitor the pH value in real time, which is also convenient for the external control device to set the alarm interval. This enables the device to realize the functions of liquid level detection protection and pH value detection protection, and has strong practicality. In addition, the device uses the liquid level detector 13 and the pH value detector 11, which can effectively control whether the raw materials meet the standards and avoid unnecessary waste.
[0034] The ulinastatin adsorption device 1 and the urokinase adsorption device 2 are connected by welding.
[0035] The inner side walls of the ulinastatin adsorption device 1 and the urokinase adsorption device 2 are both provided with nano-ceramic anti-stick coatings.
[0036] A sewage pipe 19 is provided at the bottom end of the urine supply tube 21, and a solenoid valve 18 is installed on the sewage pipe 19;
[0037] When in use, the external control device will start the solenoid valve 18, discharge the waste liquid through the sewage pipe 19, and then automatically and evenly introduce the cleaning liquid into the ulinastatin adsorption device 1 and the urokinase adsorption device 2 through the connecting hose for connecting tap water installed at the end of the sewage pipe 19 to realize the water washing function. This allows the device to be cleaned regularly as needed, ensuring the long-term stable operation of the equipment and the quality and activity of the product, which is beneficial to improving the overall stability and life of the equipment.
[0038] The working principle of the utility model is as follows: firstly, an external power supply and a control device are connected, and the urine storage tank 12 can detect the liquid level and the pH value in the urine storage tank 12 under the monitoring of the liquid level detector 13 and the pH value detector 11, and cooperate with the calculation and processing of the external control device. After meeting the requirements, the liquid level and the pH value in the urine storage tank 12 are detected by the liquid pump 5, through the flow meter 3, and flow into the urokinase adsorption device 2 at a set flow rate. After reaching the set flow rate value, the addition of urine is stopped, and the first circulation pump 6 is started. The urine flows to the first circulation pump 6 through the first conversion three-way valve 10, and flows from the first circulation pump 6 to the second conversion three-way valve 4, and flows into the interior of the urokinase adsorption device 2 from the second conversion three-way valve 4, and then flows into the first conversion three-way valve 10 from the bottom pipeline to form a cycle. After reaching the preset cycle setting time of the external control device, the urine flows from the second conversion three-way valve 4 to the second circulation pump 8, and flows into the ulinastatin adsorption device 1 from the second circulation pump 8. After the urine flows out of the urokinase adsorption device 2 and the ulinastatin adsorption device 1, it passes through the first conversion three-way valve 1 0 is convenient for timely cleaning of the inside of the device. Specifically, the external control device will start the solenoid valve 18, discharge the waste liquid through the sewage pipe 19, and then automatically and evenly introduce the cleaning liquid into the ulinastatin adsorption device 1 and the urokinase adsorption device 2 through the connecting hose for connecting tap water installed at the tail of the sewage pipe 19 to realize the water washing function. This allows the device to be cleaned regularly as needed, ensuring the long-term stable operation of the equipment and the quality and activity of the product, which is beneficial to improving the overall stability and life of the equipment. In addition, when in use, the liquid level detector 13 can be used to monitor the liquid level inside the urine storage tank 12 in real time, which is convenient for the external control device to set the alarm interval, and the pH value detector 11 can be used to monitor the pH value in real time, which is also convenient for the external control device to set the alarm interval. This enables the device to realize the functions of liquid level detection protection and pH value detection protection, and has strong practicality. In addition, the device uses the liquid level detector 13 and the pH value detector 11, which can effectively control whether the raw materials meet the standards and avoid unnecessary waste.
[0039] Obviously, the embodiments described above are only some embodiments of the utility model, not all embodiments. Based on the embodiments of the utility model, all other embodiments obtained by ordinary technicians in this field without creative work should fall within the scope of protection of the utility model.
[0040] It should be noted that the terms used herein are only for describing specific embodiments and are not intended to limit the exemplary embodiments according to the present application. As used herein, unless the context clearly indicates otherwise, the singular form is also intended to include the plural form. In addition, it should be understood that when the terms "comprise" and / or "include" are used in this specification, it indicates the presence of features, steps, operations, devices, components and / or combinations thereof.
[0041] It should be noted that the terms "first", "second", etc. in the specification and claims of the present application and the above-mentioned drawings are used to distinguish similar objects, and are not necessarily used to describe a specific order or sequence. It should be understood that the numbers used in this way can be interchanged where appropriate, so that the embodiments of the present application described herein can be implemented in an order other than those illustrated or described herein.
[0042] The above are only preferred embodiments of the present invention and are not intended to limit the present invention. For those skilled in the art, the present invention may be subject to various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.
Claims
1. A urokinase and ulinastatin on-site adsorption device, comprising a urine storage tank (12), characterized in that: Also includes An ulinastatin adsorption device (1) and a urokinase adsorption device (2), wherein the ulinastatin adsorption device (1) and the urokinase adsorption device (2) are both arranged at one end of a urine storage tank (12), a urine supply tube (21) is connected between the urine storage tank (12) and the urokinase adsorption device (2), and a liquid extraction pump (5) and a flow meter (3) are sequentially installed on the urine supply tube (21); A circulation catheter group (7) is arranged between the ulinastatin adsorption device (1) and the urokinase adsorption device (2); a first circulation pump (6) and a first conversion three-way valve (10) connected to the urokinase adsorption device (2) are installed at one end of the circulation catheter group (7); a second circulation pump (8) and a third conversion three-way valve (9) connected to the ulinastatin adsorption device (1) are installed at the other end of the circulation catheter group (7); and a second conversion three-way valve (4) is arranged between the circulation catheter group (7) and the urine supply tube (21); The ulinastatin adsorption device (1) is provided with a first filter barrel (15), a first injection column (16) and a first reaction container (17) in sequence, and the urokinase adsorption device (2) is provided with a second filter barrel (22), a second injection column (23) and a third reaction container (24) in sequence.
2. The on-site adsorption device for urokinase and ulinastatin according to claim 1, characterized in that: The liquid extraction pump (5) and the flow meter (3) are respectively installed at the bottom and the top of the urine supply tube (21).
3. The on-site adsorption device for urokinase and ulinastatin according to claim 1, characterized in that: A liquid level detector (13) is installed on the urine storage tank (12), and a pH value detector (11) is installed inside the liquid level detector (13).
4. The on-site adsorption device for urokinase and ulinastatin according to claim 1, characterized in that: The ulinastatin adsorption device (1) and the urokinase adsorption device (2) are connected by welding.
5. The on-site adsorption device for urokinase and ulinastatin according to claim 1, characterized in that: The inner side walls of the ulinastatin adsorption device (1) and the urokinase adsorption device (2) are both provided with a nano-ceramic anti-stick coating.
6. The on-site adsorption device for urokinase and ulinastatin according to claim 1, characterized in that: A sewage discharge pipe (19) is provided at the bottom end of the urine supply tube (21), and a solenoid valve (18) is installed on the sewage discharge pipe (19).